[68Ga-PSMA-I&T PET/CT for assessment of tumor burden in primary lesions of treatmentnaïve prostate cancer]

Nan Fang Yi Ke Da Xue Xue Bao. 2022 Aug 20;42(8):1143-1148. doi: 10.12122/j.issn.1673-4254.2022.08.05.
[Article in Chinese]

Abstract

Objective: To investigate the value of 68Ga-labeled prostate specific membrane antigen (PSMA) PET/CT for assessing tumor load in primary lesions for risk stratification and predicting metastasis of newly diagnosed prostate cancer (PCa).

Methods: We retrospectively analyzed the data of 36 patients (mean age 71.3 ± 8.6 years, range 56 to 89 years) with newly diagnosed PCa undergoing 68Ga-PSMA-I&T PET/CT from June 2018 to July 2019. SUVmax and SUVmean of the primary lesions were measured, and the primary PSMA tumor volume (PSMA-TV) and total lesion PSMA (TL-PSMA) were automatically measured and calculated in all the patients. The correlations of primary SUVmax, PSMA-TV, and TL-PSMA with PSA and Gleason score (GS) were analyzed, and SUVmax, PSMA-TV and TL-PSMA of the primary lesions were compared among different PCa subgroups.

Results: SUVmax, PSMA-TV and TL-PSMA of the primary lesions were all correlated with PSA and GS (P < 0.05). PCa subgroup analysis showed that SUVmax, PSMA-TV and TL-PSMA were all significantly higher in patients with PSA >20 ng/mL than in those with PSA ≤20 ng/mL (P < 0.001), and were higher in patients with a GS ≥8 than in those with a GS ≤7 (P < 0.001). PSMA-TV and TL-PSMA were significantly higher in patients with tumor metastasis than in those without metastasis (P < 0.001), while SUVmax did not differ significantly with tumor metastasis. SUVmax (P=0.002), PSMA-TV (P < 0.001), and TL-PSMA (P < 0.001) were all significantly higher in high-risk group than in low-to moderate-risk group.

Conclusion: PSMA-TV and TL-PSMA of 68Ga-PSMA-I&T PET/CT have potential value in predicting risk stratification and metastasis of newly diagnosed PCa.

目的: 探讨68Ga标记的前列腺特异性膜抗原(PSMA)PET/CT原发灶肿瘤负荷在预测初诊前列腺癌(PCa)危险分层和转移风险中的价值。

方法: 回顾性纳入2018年6月~2019年7月行68Ga-PSMA-I&T PET/CT检查的36例初诊PCa患者,年龄56~89岁,平均年龄71.3±8.6岁。测量出PCa患者原发病灶最大标准化摄取值(SUVmax)和平均标准化摄取值,分析病灶组织对68GaPSMA-I&T的摄取程度。采用三维体积分割技术自动测量出所有PCa患者原发病灶PSMA肿瘤体积(PSMA-TV)并计算出病灶PSMA代谢(TL-PSMA),分析原发灶SUVmax、PSMA-TV、TL-PSMA与血清前列腺特异性抗原(PSA)、Gleason评分(GS)的相关性。所有患者分别根据PSA水平、GS、是否转移和危险程度进行分组,包括PSA≤20 ng/mL组(22例)和PSA>20 ng/mL组(14例),GS≤7组(18例)和GS≥8(18例),非转移组(23例)和转移组(13例)、低-中危组(16例)和高危组(20例),比较不同亚组间PCa的原发病灶SUVmax、PSMA-TV、TL-PSMA之间的差异。用spearman等级相关分析不符合正态分布的定量数据之间的相关性,用Pearson相关系数分析正态分布的定量数据之间的相关性。

结果: PCa原发灶SUVmax、PSMA-TV和TL-PSMA和PSA都有相关性(r分别为0.463,0.550和0.638,P均 < 0.05),SUVmax、PSMA-TV和TL-PSMA和GS都有相关性(r分别为0.467,0.437,0.540,P均 < 0.05)。PCa亚组分析显示:PSA>20 ng/mL组的SUVmax、PSMA-TV和TL-PSMA均显著高于PSA≤20 ng/mL组(z分别为-3.606,-4.035和-4.265,P均 < 0.001)。GS≥8组的SUVmax、PSMA-TV和TL-PSMA均显著高于GS≤7组(z分别为-3.512,-4.145和-3.987,P均 < 0.001)。转移组的PSMA-TV和TL-PSMA均显著高于非转移组(z分别为-2.734,-2.421,P均 < 0.001),而非转移组和转移组SUVmax的差异无统计学意义。高风险组的SUVmax、PSMA-TV和TL-PSMA均高于低-中风险组,差异有统计学意义(z分别为-3.273,-4.155和-4.298,P分别为0.002, < 0.001, < 0.001)。

结论: 68Ga-PSMA-I&T PET/CT肿瘤负荷体积参数PSMA-TV和TL-PSMA在预测初诊PCa危险分层和转移风险中具有一定的潜在优势。

Keywords: 68Ga-PSMA-I&T; metastasis risk; prostate cancer; prostate specific membrane antigen; risk stratification; tumor load.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Edetic Acid
  • Gallium Isotopes
  • Gallium Radioisotopes
  • Humans
  • Male
  • Middle Aged
  • Oligopeptides
  • Positron Emission Tomography Computed Tomography*
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Retrospective Studies
  • Tumor Burden

Substances

  • Gallium Isotopes
  • Gallium Radioisotopes
  • Oligopeptides
  • gallium 68 PSMA-11
  • Edetic Acid
  • Prostate-Specific Antigen

Grants and funding

国家自然科学基金(11805104);江苏省重点研发专项基金(BE2017612);苏省卫健委医学科研项目(H2019091)